1-3 of 3
Antonio Mulé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study

Fabio Guolo, Luana Fianchi, Maria Paola Martelli, Patrizia Chiusolo, Federico Lussana, Francesco Grimaldi, Federica Pilo, Michela Rondoni, Carla Fili, Debora Capelli, Massimo Breccia, Sara Mastaglio, Monica Bocchia, Monica Fumagalli, Sara Galimberti, Valentina Mancini, Anna Lina Piccioni, Luca Maurillo, Raffaele Palmieri, Andrea Corbingi, Calogero Vetro, Alessandra Sperotto, Federica Gigli, Patrizia Zappasodi, Antonio Mulé, Erika Borlenghi, Michelina Dargenio, Federica Lessi, Marco Cerrano, Alessandro Isidori, Lorenzo Brunetti, Cristina Papayannidis, Monia Lunghi, Caterina Alati, Samuele Gatani, Francesco Mannelli, Nicola Fracchiolla, Michele Gottardi, Roberto Cairoli, Felicetto Ferrara, Roberto Massimo Lemoli, Adriano Venditti, Livio Pagano, Elisabetta Todisco
Journal: Blood
Blood (2023) 142 (Supplement 1): 731.
https://doi.org/10.1182/blood-2023-189025
Published: 2023
Journal Articles

Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma

Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Alessandra Romano, Caterina Patti, Corrado Schiavotto, Roberto Sorasio, Vincenzo Marasco, Laura Lissandrini, Davide Rapezzi, Daniela Gottardi, Federica Cocito, Antonio Mulé, Salvatore Leotta, Guido Gini, Marco Sorio, Enrico Derenzini, Alessandro Rambaldi, Corrado Tarella, Vincenzo Bagnardi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6179.
https://doi.org/10.1182/blood-2023-173085
Published: 2023
Journal Articles

Male Gender, Quality of Grafted Cells, Advanced Age, Rituximab and Radiotherapy Are the Main Factors That Variously Influence the Occurrence of Secondary Malignancies Following High-Dose Therapy and Autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Survey in 1,347 Lymphoma Patients.

Corrado Tarella, MD, Roberto Passera, PhD, Michele Magni, MD, Andrea Rossi, MD, Fabio Benedetti, MD, Angela Gueli, Jr., MD, Caterina Patti, MD, Guido Parvis, MD, Fabio Ciceri, MD, Andrea Gallamini, MD, Sergio Cortelazzo, MD, Paolo Corradini, MD, Valerio Zoli, MD, Antonio Mule', MD, Roberto Crocchiolo, MD, Marco Bosa, MD, Anna Barbui, MD, Massimo Di Nicola, MD, Daniele Caracciolo, MD, Marco Sorio, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 519.
https://doi.org/10.1182/blood.V114.22.519.519
Published: 2009